GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Key Protein AmelOBP4 Identified as Crucial for Honey Bee Olfactory Function

by GOAI
Share To

Scientists have identified a key protein, AmelOBP4, that is crucial for the olfactory abilities of honey bees. Recent research highlights that this gene encodes an antenna-specific odor-binding protein, which significantly influences how honey bees detect and respond to environmental scents. The study sheds light on the molecular mechanisms underlying the insects’ sense of smell, a critical function for their survival and ecological role.

Researchers focused on the AmelOBP4 gene due to its specific expression in the antennae of honey bees, where scent detection occurs. The study revealed that this protein binds to odor molecules, enabling bees to recognize and react to various chemical signals in their surroundings. These findings provide new insights into the sensory biology of honey bees and could have implications for understanding pollination behaviors and colony dynamics. Further details about the research are available through scientific publications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top